Electra Therapeutics Inc. (ETRA)
ETRA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.61
-7.62% on the day
Market cap
$540.4M
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ETRA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002088082 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-09-18 |
| Latest current report | 8-K | 2026-09-21 |
Source: SEC EDGAR submissions feed, 33 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.0% |
| 1 month | Not enough price history |
| 3 months | Not enough price history |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -34.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DBVT | DBV Technologies S.A. | $9.03 | -5.45% | $534.7M |
| VALN | Valneva SE | $5.56 | -6.24% | $527.6M |
| PRME | Prime Medicine Inc. | $3.32 | -8.03% | $602.2M |
| RGNX | REGENXBIO Inc. | $7.26 | -6.56% | $479.3M |
| PROK | ProKidney Corp. | $1.57 | -5.99% | $474.6M |
| SLDB | Solid Biosciences Inc. | $5.82 | -13.26% | $624.1M |
| AURA | Aura Biosciences Inc. | $6.27 | -4.13% | $650.2M |
| ALLO | Allogene Therapeutics Inc. | $1.29 | -7.86% | $445.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier